Keith Woods, the Chief Operating Officer of $SRRK, sold 10,220 shares of the company on 04-16-2026 for an estimated $506,651. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.6% of their shares of this class of stock. Following this trade, they now own 620,055 shares of this class of $SRRK stock.
$SRRK Insider Trading Activity
$SRRK insiders have traded $SRRK stock on the open market 25 times in the past 6 months. Of those trades, 0 have been purchases and 25 have been sales.
Here’s a breakdown of recent trading of $SRRK stock by insiders over the last 6 months:
- MO QATANANI (CHIEF SCIENTIFIC OFFICER) has made 0 purchases and 9 sales selling 189,351 shares for an estimated $8,603,281.
- DAVID HALLAL (Chief Executive Officer) has made 0 purchases and 2 sales selling 88,065 shares for an estimated $3,970,838.
- AKSHAY VAISHNAW (President of R&D) has made 0 purchases and 2 sales selling 32,684 shares for an estimated $1,479,791.
- VIKAS SINHA (Chief Financial Officer) has made 0 purchases and 2 sales selling 27,165 shares for an estimated $1,231,509.
- KEITH WOODS (Chief Operating Officer) has made 0 purchases and 2 sales selling 26,966 shares for an estimated $1,221,705.
- JUNLIN HO (GENERAL COUNSEL) has made 0 purchases and 2 sales selling 17,596 shares for an estimated $802,273.
- CARYN PARLAVECCHIO (CHRO) has made 0 purchases and 2 sales selling 15,635 shares for an estimated $713,935.
- JING L. MARANTZ (CHIEF MEDICAL OFFICER) has made 0 purchases and 2 sales selling 9,955 shares for an estimated $451,299.
- KATIE PENG has made 0 purchases and 2 sales selling 1,006 shares for an estimated $44,351.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$SRRK Hedge Fund Activity
We have seen 159 institutional investors add shares of $SRRK stock to their portfolio, and 104 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ORBIS ALLAN GRAY LTD added 3,126,677 shares (+1034.5%) to their portfolio in Q4 2025, for an estimated $137,730,121
- FAIRMOUNT FUNDS MANAGEMENT LLC removed 1,824,031 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $80,348,565
- SIREN, L.L.C. added 1,575,008 shares (+17.0%) to their portfolio in Q4 2025, for an estimated $69,379,102
- FMR LLC added 1,368,597 shares (+9.8%) to their portfolio in Q4 2025, for an estimated $60,286,697
- REDMILE GROUP, LLC added 1,316,390 shares (+33.7%) to their portfolio in Q4 2025, for an estimated $57,986,979
- SAMSARA BIOCAPITAL, LLC added 1,284,756 shares (+22.9%) to their portfolio in Q4 2025, for an estimated $56,593,501
- JANUS HENDERSON GROUP PLC removed 1,239,277 shares (-41.1%) from their portfolio in Q4 2025, for an estimated $54,590,151
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$SRRK Analyst Ratings
Wall Street analysts have issued reports on $SRRK in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- UBS issued a "Buy" rating on 01/07/2026
- JP Morgan issued a "Overweight" rating on 11/18/2025
- Wolfe Research issued a "Outperform" rating on 11/18/2025
- Barclays issued a "Overweight" rating on 11/17/2025
To track analyst ratings and price targets for $SRRK, check out Quiver Quantitative's $SRRK forecast page.
$SRRK Price Targets
Multiple analysts have issued price targets for $SRRK recently. We have seen 10 analysts offer price targets for $SRRK in the last 6 months, with a median target of $58.0.
Here are some recent targets:
- David Nierengarten from Wedbush set a target price of $58.0 on 04/01/2026
- Tessa Romero from JP Morgan set a target price of $50.0 on 03/16/2026
- Allison Bratzel from Piper Sandler set a target price of $58.0 on 03/04/2026
- Srikripa Devarakonda from Truist Securities set a target price of $55.0 on 03/04/2026
- Etzer Darout from Barclays set a target price of $53.0 on 03/04/2026
- Etzer Darout from BMO Capital set a target price of $70.0 on 03/04/2026
- Geoff Meacham from Citigroup set a target price of $58.0 on 03/04/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
